Simon Nebel has participated in the financing of several life science companies and M&A transactions for Aravis portfolio companies. He co-founded Aravis Energy I LP, the first Swiss Limited Partnership focused on renewable energy. He has served as a board member or observer in fourteen companies and is currently a board member of SynAffix (NL), MarinoMed (AT), Bird Rock Bio (La Jolla/USA), and BioSilu Healthcare (DE). Prior to Aravis, he was a group strategist at UBS in London, Basel, and Zurich, where he worked on business planning and modelling, including developing a Biotechnology Venture Capital proposal for UBS Capital. He holds a PhD in Biophysics from the Biocentre of the University of Basel (1996) and an MBA with distinction from the London Business School (2001).
BioTech, Energy
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...